Bacterial-derived antimicrobial polypeptides enjoy a large degree of struct
ural and chemical diversity. Two well-studied examples of such polypeptides
are the lanthionine-containing lantibiotics produced by a variety of Gram-
positive bacteria, and their Gram-negative counterparts, the microcins. Bot
h groups are produced as gene-encoded precursor peptides and undergo post-t
ranslational modification to generate the active moieties. Structure elucid
ation of novel lantibiotics and microcins has recently uncovered further no
vel structural and chemical features and, combined with the generation of a
nalogue peptides by genetic manipulation, new insights into structure-funct
ion relationships have been gained. Furthermore, study of the mode of actio
n of the antibiotics nisin and mersacidin has revealed their use of a 'dock
ing molecule' in the target cell to facilitate their biological activities.
Meanwhile, in vitro studies with microcin B17 have helped to uncover the m
olecular mechanisms by which post-translational modification results in the
formation of heterocyclic oxazole and thiazole rings. From a practical sta
ndpoint, bath groups of polypeptides represent new lead structures for futu
re development of antimicrobial agents, whilst the identification of the 'd
ocking molecules' represents a step forward in the search for novel targets
for future antibiosis.